116 related articles for article (PubMed ID: 2967114)
1. [Determination of immunocomplexes. III. A method using a solid surface for immunocomplex binding and use of C1q subcomponent of the first complement component (C1q SP)].
Votruba T; Rákosník P
Cesk Epidemiol Mikrobiol Imunol; 1988 Feb; 37(1):15-22. PubMed ID: 2967114
[No Abstract] [Full Text] [Related]
2. [Determination of immunocomplexes. I. The C1q subunit of the first complement component and using its qualification in the determination of circulating immunocomplexes].
Votruba T; Rákosník P; Vancurík J
Cesk Epidemiol Mikrobiol Imunol; 1985 Nov; 34(6):321-8. PubMed ID: 2934147
[No Abstract] [Full Text] [Related]
3. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
Kasukawa R
Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
[No Abstract] [Full Text] [Related]
4. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
6. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
Belozerov AP
Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
Heinz HP; Dlugonska H; Rüde E; Loos M
J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
[TBL] [Abstract][Full Text] [Related]
8. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
9. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
10. [The liquid phase C1q binding assay and its clinical application].
Cheng PZ; Dong Y; Zhang NZ; Ji D; Dai X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):69-71. PubMed ID: 2954693
[No Abstract] [Full Text] [Related]
11. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
12. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
[No Abstract] [Full Text] [Related]
13. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
14. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
Loos M
Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
[No Abstract] [Full Text] [Related]
15. [Problems in the determination of immunocomplexes. II. C1q binding test].
Votruba T; Rákosník P
Cesk Epidemiol Mikrobiol Imunol; 1986 Jul; 35(4):239-45. PubMed ID: 2942267
[No Abstract] [Full Text] [Related]
16. [The effect of ampicillin on the measurement of circulating immune complex by C1q solid-phase enzyme immunoassay].
Tokuyama K; Mitsuhashi M; Tajima K; Morikawa A; Tamura H
Arerugi; 1984 Jul; 33(7):418-23. PubMed ID: 6388531
[No Abstract] [Full Text] [Related]
17. Enzyme immunoassay of C1q and its application to the detection of C1q antigens in urine.
Takada Y; Shirahama S; Nagase M; Takada A
J Clin Lab Immunol; 1985 Mar; 16(3):169-72. PubMed ID: 3897545
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).
Glikmann G; Svehag SE
Methods Enzymol; 1981; 74 Pt C():571-88. PubMed ID: 6798369
[No Abstract] [Full Text] [Related]
19. The use of glass as solid phase in enzyme immunoassay as exemplified by the detection of circulating immune complexes.
Schössler W; Hiepe F; Montag T; Schmidt HE
Biomed Biochim Acta; 1985; 44(7-8):1247-53. PubMed ID: 3910036
[TBL] [Abstract][Full Text] [Related]
20. C1q binding and C1 activation by various isolated cellular membranes.
Storrs SB; Kolb WP; Olson MS
J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
